Treatment of cardiac iron overload in thalassemia major.
Mark
M
Westwood
Lisa J
LJ
Anderson
Dudley J
DJ
Pennell
D009202:Cardiomyopathies / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D000077543:Deferiprone; D003676:Deferoxamine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006331:Heart Diseases / Q000453:epidemiology / Q000209:etiology / Q000401:mortality; D006801:Humans; D007501:Iron / Q000032:analysis; D007502:Iron Chelating Agents / Q000627:therapeutic use*; D019190:Iron Overload / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D008099:Liver / Q000737:chemistry; D009206:Myocardium / Q000737:chemistry; D011728:Pyridones / Q000627:therapeutic use; D017086:beta-Thalassemia / Q000150:complications*
D007502:Iron Chelating Agents; D011728:Pyridones; D000077543:Deferiprone; D007501:Iron; D003676:Deferoxamine